Bixiye
QP3-22 Commercial Pharmacy Benefit Exclusion for Loreev XR and Sertraline Capsules
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Natiijooyinka Raadinta
Soo bandhiga 2551 - 2560 ee natiijooyinka 4128
Bixiye
QP4-22 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
QP5-22 New Access Point for Prior Authorization Look Up Tool and Blue Cross Website Updates
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
QP6-22 New Telehealth Place of Service Code 10
Taariikhda uu dhaqangalayo Barnaamijka: Jan 12, 2022
Bixiye
P1-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Jan 03, 2022
Bixiye
P2-22 Removal of Prior Authorization Requirement - Effective January 31, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Jan 03, 2022
Bixiye
P3-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: Jan 03, 2022
Bixiye
P4-22 Request a Prior Authorization Extension for Delayed Procedures
Taariikhda uu dhaqangalayo Barnaamijka: Jan 03, 2022
Bixiye
2022 January Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Jan 03, 2022
Bixiye
Accrufer (ferric maltol) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025